Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma

This study has been completed.
Sponsor:
Collaborators:
Schering-Plough
Eisai Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00791271
First received: November 12, 2008
Last updated: May 19, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)